Tag: Novartis
Breaking News: FDA Approves Treatment for pNET Patients
For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients! The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients. This is a milestone for the carcinoid/NET…
READ MORE
Carcinoid Cancer Foundation Thanks Symposium Sponsors
There’s still time to register for the Carcinoid Cancer Foundation’s 14th annual symposium for patients, family, friends, and healthcare professionals, which will be held on Sunday, May 1st at Mount Sinai Medical Center in New York City. The Foundation…
READ MORE
CNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals
Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…
READ MORE
Carcinoid Cancer Foundation to Speak on Behalf of NET Cancer Patients at April 12, 2011 FDA Oncologic Drugs Advisory Committee Meeting
Grace Goldstein, Chief Operating Officer of the Carcinoid Cancer Foundation, will speak at the Open Public Hearing segment during the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee Meeting on April 12, 2011 in Silver …
READ MORE
iWalk for Carcinoid
iWalk for Carcinoid is a virtual walkathon to help raise money for carcinoid-related organizations. The Carcinoid Cancer Foundation is one of the organizations selected to benefit from this virtual walkathon. Each organization has the opportunity…
READ MORE
12 iPhone Apps for Patients and Physicians
For carcinoid and neuroendocrine cancer iPhone users there are many resources for you as a patient or for your physician that have been created by big pharmaceutical companies around the world. These pharma companies include Novartis, Pfizer, Merck…
READ MORESandostatin Mobile Administration Program for Carcinoid Syndrome Patients
If you are a carcinoid patient who needs Sandostatin® LAR Depot injections, you may be eligible for the Mobile Administration Program. This program helps alleviate the stress of driving to a doctor’s office (or finding one where you live or while on vacation),…
READ MORE
Video Recording of National Carcinoid Cancer and Neuroendocrine Tumor Patient Conference Now Online
Whether you are newly diagnosed with carcinoid cancer or another neuroendocrine tumor or you are seeking novel treatments for NETs you can gain invaluable information from the video recording of the 2009 National Carcinoid/NET Patient Conference …
READ MORE
